Anzeige
Mehr »
Mittwoch, 18.02.2026 - Börsentäglich über 12.000 News
Noch unter 2x Umsatz bewertet - aber wie lange noch?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
163 Leser
Artikel bewerten:
(1)

Periodontal Disease Treatment Market worth $3.86 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., Feb. 18, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Periodontal Disease Treatment Market is projected to grow from about USD 2.86 billion in 2026 to USD 3.86 billion by 2031, at a CAGR of 6.2%.

MarketsandMarkets Logo

Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Periodontal Disease Treatment Market- Global Forecast to 2031"

Periodontal Disease Treatment Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 2.86 billion
  • 2031 Projected Market Size: USD 3.86 billion
  • CAGR (2026-2031): 6.2%

Periodontal Disease Treatment Market Trends & Insights:

  • Based on product, the equipment segment accounted for a larger share of 50.6% of the periodontal disease treatment market in 2025.
  • Based on end user, hospitals held the largest share of ~54.0% in the periodontal disease treatment market in 2025.
  • Europe accounted for a larger share of 36.2% of periodontal disease treatment market in 2025.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=84851649

The market for treatment of periodontal disease is climbing a moderate upward trend as the world sees more and more cases of gum disorders due to poor oral hygiene, excessive use of tobacco, unhealthy diet, and systemic diseases like diabetes, which worsen periodontal conditions. Oral health awareness and recognition of periodontal disease as a significant factor affecting a person's general health have led to more people being screened early and seeking treatment. Besides that, progressive changes in dental technology, such as less-invasive methods, laser-assisted treatment, regenerative therapy, and better diagnostic tools, have resulted in remarkable clinical outcomes and increased patient comfort, leading to wider acceptance of the procedures. Moreover, an increase in the number of elderly people who are generally at high risk of developing periodontal diseases, dental care becoming more accessible, healthcare spending being on the rise, and the expansion of dental insurance coverage in many parts of the world together make the case for the periodontal disease treatment market to keep on growing.

By treatment type, non-surgical treatment accounted for the largest share in 2025.

In the treatment type segment, the largest market share is held by non-surgical treatments, mainly because of their widespread adoption as the primary mode of treatment for the disease, especially for conditions such as gingivitis and stage I periodontitis. This is mainly because of the efficiency as well as the cost-effectiveness of the treatment process, as well as its ability to handle the disease effectively. This process does not require a highly sophisticated infrastructure, mainly because of the relatively less invasive nature of the treatment process, especially when done in the dental setting.

Request Sample Pages @https://www.marketsandmarkets.com/requestsampleNew.asp?id=84851649

By end user, The hospitals segment accounted for the largest share of the periodontal disease treatment market in 2025.

In the end-user market, hospitals hold the largest market share. This is because they can provide overall dental and periodontal care to patients. Hospitals have advanced diagnostic imaging facilities and dental surgeons who can provide treatment for periodontal diseases. They also have the capability to treat patients in larger volumes because they have the capability to treat patients who have severe periodontal diseases or patients who have various other health-related problems that need overall treatment. Due to these factors, it can be concluded that hospitals have the largest share in the market for the treatment of periodontal diseases.

Inquire Before Buying @https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=84851649

Top Companies in Periodontal Disease Treatment Market:

The Top Companies in Periodontal Disease Treatment Market include Dentsply Sirona (US), Henry Schein, Inc. (US), Nakanishi Inc. (Japan), Yoshida Dental MFG. Co., Ltd. (Japan), Institut Straumann Holdings AG (Switzerland), Envista Holdings Corporation (US), BIOLASE, Inc. (US), and other players.

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Dental Bone Graft Substitutes Market - Global Forecast to 2031

Dental Equipment Market - Global Forecast to 2031

Dental Imaging Market - Global Forecast to 2030

Dental Implants and Prosthetics Market - Global Forecast to 2030

Dental Consumables Market - Global Forecast to 2030

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/periodontal-disease-treatment-market-worth-3-86-billion-by-2031--marketsandmarkets-302691262.html

© 2026 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.